Brief: Alembic Pharmaceuticals Passes ANVISA GMP Inspection For API-III Facility At Karakhadi
15/05/2026 16:25
May 15 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: PASSES ANVISA GMP INSPECTION FOR API-III FACILITY AT KARAKHADI COMPLETES ANVISA GMP INSPECTION FOR MULTIPLE APIS WITHOUT OBSERVATION Source text: ID:nBSE2N1s8F Further company coverage: ALEM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand